The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.

The medication, typically used for weight loss or diabetes treatment, is showing promise curbing cravings for alcohol and ...

Labcorp posted first-quarter 2026 revenue of $3.54 billion, up 5.8% year over year, and adjusted earnings per share of $4.25, exceeding prior-year results. The company raised its full-year revenue and ...